American Airlines Group (AAL) shares dropped approximately 17% over the last 30 days, falling from $17.92 on June 29, 2026, to around $14.83 on July 29, as surging jet fuel costs overwhelmed strong revenue growth. The sharp decline was triggered primarily by a lowered full-year earnings forecast announced with Q2 results on July 23, in which the carrier cut its 2026 adjusted EPS guidance to a range of -$0.65 to +$0.65, implying breakeven at the midpoint.

Primoris Services Corporation (PRIM) shares have declined approximately 23% over the past 30 days, falling from $97.24 on June 29, 2026, to $74.79 as of July 29, 2026. The 30-day slide extends a brutal multi-month selloff that has erased roughly 63% of the stock's value since late April 2026, when shares traded near $200.

GLD gained +1.19% during Wednesday's regular session, rebounding to $373.78 after Tuesday's close at $369.37, as gold bounced off the psychological $4,000/oz support level. Dip-buyers stepped in following yesterday's decline, with spot gold recovering from near-$4,000 to trade around $4,036/oz ahead of the Fed decision.

WSO plunged -16.35% during regular trading after reporting Q2 2026 earnings that badly missed Wall Street expectations. The company posted EPS of $4.00 versus analyst estimates of $4.41, with revenue also coming in slightly below the $2.1 billion consensus forecast.

OI plunged -18.1% during Wednesday's regular session, extending steep after-hours and premarket losses following its Q2 2026 earnings release after Tuesday's close. The primary catalyst: adjusted EPS of just $0.09 badly missed the $0.24–$0.29 consensus, while Europe segment operating profit collapsed 93% year-over-year to only $6 million.

AAUC shares plunged -17.61% during regular trading after the $4 billion (C$5.5B) takeover by Zijin Gold was officially terminated. The deal collapsed because Chinese regulatory approval was not obtained before the July 29 deadline, with both companies agreeing conditions would not be met in any reasonable timeframe.

BAND tumbled -28.88% in today's session after reporting Q2 results before the open, falling from a previous close of $52.25 to approximately $37.16 intraday. The selloff was driven by a cut to full-year adjusted earnings guidance to $1.71–$1.79 per share, down from $1.77–$1.83, missing the analyst consensus of $1.80.

Nebius Group (NBIS) shares declined approximately 27.7% over the last 30 days, falling from $259.66 on June 24 to $187.77 on July 24, 2026. The sell-off accelerated after the stock peaked near $299.86 on June 22, driven by profit-taking, valuation concerns, and growing skepticism around the neocloud business model.

VRRM surged +30.86% to approximately $5.47 during regular trading on July 29, after initially spiking +26% in after-hours trading on July 28. The rally was triggered by the company's announcement that it reached a framework agreement with Avis Budget Group on key commercial terms for a new seven-year tolling and violations services contract.

PSN plunged -40.42% during regular trading hours after reporting disastrous Q2 CY2026 results before the market opened. The primary catalyst was a massive earnings miss: adjusted EPS came in at just $0.06 versus analyst estimates of $0.76, a -92.1% shortfall driven by $118 million in portfolio action charges and a joint venture program loss.

LMND plunged -20.09% to $49.63 after reporting Q2 2026 results, with the sell-off beginning in premarket trading and accelerating into the regular session. The company beat revenue estimates ($294.4M vs. $290.9M consensus) and posted in-line EPS of -$0.56, but the print failed to satisfy elevated investor expectations.

AXS plunged -11.77% during regular trading on July 29, opening sharply lower from the prior session's close of $119.27 and falling to near $105 intraday, erasing weeks of gains in a single session. The primary catalyst was a geopolitical shock: President Trump announced the U.S.-Iran ceasefire had collapsed, with military strikes hitting Gulf energy and shipping assets, directly threatening specialty insurers and reinsurers with major claim exposure.

VFC shares plunged approximately -14.1% intraday after reporting Q1 FY2027 adjusted EPS of -$0.27, missing consensus estimates of -$0.22 by $0.05. The drop began in premarket trading and accelerated during the regular session, erasing the +6.6% gain from the prior day's close of $18.25.

Masco shares plunged -10.51% in regular trading following the company's Q2 2026 earnings release, dropping from a prior close of $81.61 to approximately $73.03. The decline was triggered by a Q2 revenue miss of $1.99 billion versus the $2.08 billion consensus, representing a -3% year-over-year decline, despite adjusted EPS of $1.64 beating estimates by 25%.

LII shares fell -14.79% during regular trading after reporting Q2 2026 results before the market opened, erasing months of gains in a single session. Q2 revenue of $1.55B narrowly missed the $1.56B consensus estimate, while GAAP EPS of $7.72 was roughly in line with the $7.73 analyst consensus.

BSX dropped -5.88% during premarket and early regular trading after reporting Q2 2026 results that beat estimates but included a sharp guidance cut. Q2 earnings topped consensus: adjusted EPS of $0.86 vs. $0.83 expected, and revenue of $5.44 billion vs. $5.36 billion, driven by 7.5% year-over-year sales growth.

VRT tumbled approximately -10.1% during regular trading Wednesday after its Q2 2026 earnings report beat on profit but missed on revenue, triggering a sharp selloff. Adjusted EPS of $1.52 surpassed the $1.42 consensus by +6.4%, yet revenue of $3.27B fell roughly -3.4% short of the $3.38B analyst estimate, overshadowing the bottom-line beat.

Profit surge: Underlying earnings jumped 43% year-over-year to $6.85 billion for the half year ended June 30, 2026, the highest half-year profit in four years. Revenue growth: Consolidated sales revenue rose 15% to $31.03 billion, supported by higher commodity prices and increased production volumes across key commodities.

Revenue beat: GSK posted second-quarter turnover of £8.41 billion, exceeding the analyst consensus of £8.24 billion and rising 5% at constant exchange rates (CER). Profit outperformance: Core operating profit reached £2.80 billion, ahead of the £2.68 billion consensus, while core earnings per share (EPS) of 50.5 pence comfortably beat the 47.1 pence forecast.

Core sales rose 17% year over year to $4.74 billion, surpassing the consensus estimate of approximately $4.62 billion. Core earnings per share (EPS) climbed 30% to $0.78, beating analyst expectations of $0.75 to $0.76.